Literature DB >> 26622586

Successful treatment of gastrointestinal stromal tumor with multiple liver metastases with radiofrequency ablation and imatinib: A case report.

Chunchuan Fu1, Nianzhou Liu1, Qingsong Deng1, Yunhua Tan1, Kuansheng Ma1, Ping Bie1.   

Abstract

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumor of the gastrointestinal tract, and typically metastasize to the liver. In patients with recurrent metastatic GISTs, no single treatment is effective. The current study reports a case of GIST with 27 metastases in the liver, which was successfully treated using radiofrequency ablation (RFA) combined with surgical resection and imatinib therapy. The patient remains tumor-free 36 months after the first RFA treatment. This case suggests that comprehensive therapy including surgical resection, RFA and imatinib, may be an effective strategy for the treatment of GIST with multiple liver metastases.

Entities:  

Keywords:  gastrointestinal stromal tumor; liver metastasis; radiofrequency ablation

Year:  2015        PMID: 26622586      PMCID: PMC4509452          DOI: 10.3892/ol.2015.3285

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  15 in total

1.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Authors:  R P DeMatteo; J J Lewis; D Leung; S S Mudan; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  [Successful treatment of a gastrointestinal stromal tumor with liver metastases in a case that tolerated imatinib administration, by radiofrequency ablation using contrast-enhanced ultrasonography].

Authors:  Tatsuya Minami; Shinpei Sato; Yoshitaka Watanabe; Rie Matsuda; Satoru Yotsuya; Akishige Yamada; Teruyuki Tanaka; Shintaro Kondo; Tetsuo Ebihara; Gouichi Togo; Kazuto Yamazaki; Yasuo Ishida
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  2010-03

3.  Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients.

Authors: 
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

4.  Surgery including liver resection for metastatic gastrointestinal stromal tumors or gastrointestinal leiomyosarcomas.

Authors:  Souya Nunobe; Tsuyoshi Sano; Kazuaki Shimada; Yoshihiro Sakamoto; Tomoo Kosuge
Journal:  Jpn J Clin Oncol       Date:  2005-05-31       Impact factor: 3.019

5.  Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver.

Authors:  Timothy M Pawlik; Jean-Nicolas Vauthey; Eddie K Abdalla; Raphael E Pollock; Lee M Ellis; Steven A Curley
Journal:  Arch Surg       Date:  2006-06

6.  [A case of gastrointestinal stromal tumor with liver and bone metastases effectively treated with radiofrequency ablation and imatinib mesylate].

Authors:  Akihisa Ishikawa; Takuma Teratani; Satoshi Ono; Toshihiro Ochiai; Nobushige Kakinoki; Yosuke Kishimoto; Toshirou Kamoshida; Shinji Hirai; Yuji Oka; Tatsuro Shimokama
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  2006-11

Review 7.  Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  Arch Pathol Lab Med       Date:  2006-10       Impact factor: 5.534

8.  Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.

Authors:  Charles D Blanke; George D Demetri; Margaret von Mehren; Michael C Heinrich; Burton Eisenberg; Jonathan A Fletcher; Christopher L Corless; Christopher D M Fletcher; Peter J Roberts; Daniela Heinz; Elisabeth Wehre; Zariana Nikolova; Heikki Joensuu
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

9.  Aggressive surgical resection for the management of hepatic metastases from gastrointestinal stromal tumours: a single centre experience.

Authors:  D Gomez; A Al-Mukthar; K V Menon; G J Toogood; J P A Lodge; K R Prasad
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

10.  Radiofrequency ablation is a feasible therapeutic option in the multi modality management of sarcoma.

Authors:  R L Jones; J McCall; A Adam; D O'Donnell; S Ashley; O Al-Muderis; K Thway; C Fisher; I R Judson
Journal:  Eur J Surg Oncol       Date:  2010-01-08       Impact factor: 4.424

View more
  2 in total

1.  Radiotherapy in the management of gist: state of the art and new potential scenarios.

Authors:  L Gatto; M Nannini; M Saponara; V Di Scioscio; G Beltramo; G P Frezza; G Ercolani; A D Pinna; A Astolfi; M Urbini; G Brandi; G Biasco; M A Pantaleo
Journal:  Clin Sarcoma Res       Date:  2017-01-10

Review 2.  Endoscopic ultrasound-guided ethanol and radiofrequency ablation of pancreatic insulinomas: a systematic literature review.

Authors:  Ghassan El Sayed; Levente Frim; Jamie Franklin; Raymond McCrudden; Charles Gordon; Safa Al-Shamma; Szabolcs Kiss; Péter Hegyi; Bálint Erőss; Péter Jenő Hegyi
Journal:  Therap Adv Gastroenterol       Date:  2021-11-18       Impact factor: 4.409

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.